These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 12569961

  • 1. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF.
    Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Botulinum toxin therapy for focal dystonia].
    Hahn K, Niklai E, Garzuly F, Szupera Z.
    Orv Hetil; 2009 Jul 19; 150(29):1381-4. PubMed ID: 19581172
    [Abstract] [Full Text] [Related]

  • 5. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD.
    Clin Ther; 2007 Jul 19; 29(7):1325-37. PubMed ID: 17825685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses.
    Charles PD.
    Am J Health Syst Pharm; 2004 Nov 15; 61(22 Suppl 6):S11-23. PubMed ID: 15598005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R, Morales B, Sánchez V, Peñafiel N, Rábano J, Oliván J, García de Yébenes J.
    Arch Neurobiol (Madr); 1991 Nov 15; 54 Suppl 3():44-51. PubMed ID: 1810208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
    Berardelli A, Carta A, Stocchi F, Formica A, Agnoli A, Manfredi M.
    Ital J Neurol Sci; 1990 Dec 15; 11(6):589-93. PubMed ID: 2081684
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R, Cardoso F, Truong DD.
    Eur J Neurol; 2006 Feb 15; 13 Suppl 1():21-9. PubMed ID: 16417594
    [Abstract] [Full Text] [Related]

  • 16. Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm.
    Hast MA, Kong AM, Desai S, Back S, Syed S, Holmes J.
    Toxins (Basel); 2024 Aug 16; 16(8):. PubMed ID: 39195772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.